METHOD FOR PRODUCING OPTICALLY ACTIVE 2-(N-SUBSTITUTED AMINOMETHYL)-3-HYDROXYBUTYRIC ACID ESTER
The present invention relates to a method for producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters wherein a 2-(N-substituted aminomethyl)-3-oxobutyric acid ester is treated with an enzyme source capable of stereoselectively reducing said ester to the corresponding optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester having the (2S,3R) configuration. The present invention provides an efficient method for industrially producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters, in particular such compounds having the (2S,3R) configuration, which are useful as intermediates for the production of medicinal compounds, among others.
1 . A method for producing optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid esters represented by the general formula (5):
(wherein R 1 represents a lower alkyl group, which may optionally be substituted, an allyl group, an aryl group, which may optionally be substituted, or an aralkyl group, which may optionally be substituted and, as for R 2 and R 3 ,
1) R 3 is a hydrogen atom and R 2 represents a lower alkyl group, which may optionally be substituted, an alkoxy group, which may optionally be substituted, an aryl group, which may optionally be substituted, or an aralkyloxy group, which may optionally be substituted, or
2) R 3 and —COR 2 together represent a phthaloyl group):, wherein a 2-(N-substituted aminomethyl)-3-oxobutyric acid ester represented by the general formula (6):
(wherein R 1 , R 2 and R 3 are as defined above): is treated with an enzyme source capable of stereoselectively reducing said ester to the corresponding optically active 3-hydroxybutyric acid ester having the (2S,3R) configuration.
2 . The method according to claim 1 wherein a compound represented by the general formula (1):
(wherein R 1 is as defined above, R 2 represents a lower alkyl group, which may optionally be substituted, a lower alkoxy group, which may optionally be substituted, an aryl group, which may optionally be substituted, or an aralkyloxy group, which may optionally be substituted): is produced, as the optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester represented by the formula (5), using a compound represented by the general formula (2):
(wherein R 1 and R 2 are as defined above): as the 2-(N-substituted aminomethyl)-3-oxobutyric acid ester represented by the formula (6).
3 . The method according to claim 1 wherein a compound represented by the general formula (3):
(wherein R 1 is as defined above): is produced, as the optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester represented by the formula (5), using a compound represented by the general formula (4):
(wherein R 1 is as defined above): as the 2-(N-substituted aminomethyl)-3-oxobutyric acid ester represented by the formula (6).
4 . The method according to claim 1 wherein the enzyme source is an enzyme derived from the microorganism selected from the group consisting of microorganisms belonging to the genera Candida, Geotrichum, Galactomyces, Saccharomycopsis, Achromobacter, Arthrobacter, Bacillus, Brevundimonas, Xanthomonas, Devosia, Ralstonia, Lactobacillus, Leuconostoc, Microsporum and Moniliella.
5 . The method according to claim 4 wherein the enzyme source is an enzyme derived from the microorganism selected from the group consisting of microorganisms of such species as Candida kefyr, Candida oleophila, Candida maris, Geotrichum eriense, Galactomyces reessii, Saccharomycopsis malanga, Achromobacter xylosoxidans, Achromobacter denitrificans, Arthrobacter paraffineus, Arthrobacter nicotianae, Bacillus amylolyticus, Bacillus circulans, Bacillus cereus, Bacillus badius, Bacillus sphaericus, Brevundimonas diminuta, Xanthomonas sp., Devosia riboflavina, Ralstonia eutropha, Lactobacillus brevis, Lactobacillus helveticus, Leuconostoc pseudomesenteroides, Microsporum cookei and Moniliella acetoabatens.
6 . The method according to claim 1 wherein R 1 is a methyl group, an ethyl group, a propyl group, or an n-butyl group.
7 . The method according to claim 6 wherein R 1 is a methyl group.
8 . The method according to claim 1 wherein R 2 is a phenyl group, a p-nitrophenyl group, or a p-chlorophenyl group.
9 . The method according to claim 8 wherein R 2 is a phenyl group.
10 . The method according to claim 1 wherein R 1 is a methyl group, and R 2 is a phenyl group.
11 . The method according to claim 1 wherein an enzyme reducing either or both of oxidized nicotinamide adenine dinucleotide (NAD + ) and oxidized nicotinamide adenine dinucleotide phosphate (NADP + ) to the respective reduced form, and a substrate for the reduction coexist.
12 . The method according to claim 2 wherein the enzyme source is an enzyme derived from the microorganism selected from the group consisting of microorganisms belonging to the genera Candida, Geotrichum, Galactomyces, Saccharomycopsis, Achromobacter, Arthrobacter, Bacillus, Brevundimonas, Xanthomonas, Devosia, Ralstonia, Lactobacillus, Leuconostoc, Microsporum and Moniliella.
13 . The method according to claim 3 wherein the enzyme source is an enzyme derived from the microorganism selected from the group consisting of microorganisms belonging to the genera Candida, Geotrichum, Galactomyces, Saccharomycopsis, Achromobacter, Arthrobacter, Bacillus, Brevundimonas, Xanthomonas, Devosia, Ralstonia, Lactobacillus, Leuconostoc, Microsporum and Moniliella.
14 . The method according to claim 2 wherein R 1 is a methyl group, an ethyl group, a propyl group, or an n-butyl group.
15 . The method according to claim 3 wherein R 1 is a methyl group, an ethyl group, a propyl group, or an n-butyl group.
16 . The method according to claim 2 wherein R 2 is a phenyl group, a p-nitrophenyl group, or a p-chlorophenyl group.
17 . The method according to claim 2 wherein R 1 is a methyl group, and R 2 is a phenyl group.
18 . The method according to claim 2 wherein an enzyme reducing either or both of oxidized nicotinamide adenine dinucleotide (NAD + ) and oxidized nicotinamide adenine dinucleotide phosphate (NADP + ) to the respective reduced form, and a substrate for the reduction coexist.
19 . The method according to claim 3 wherein an enzyme reducing either or both of oxidized nicotinamide adenine dinucleotide (NAD + ) and oxidized nicotinamide adenine dinucleotide phosphate (NADP + ) to the respective reduced form, and a substrate for the reduction coexist.
20 . The method according to claim 4 wherein an enzyme reducing either or both of oxidized nicotinamide adenine dinucleotide (NAD + ) and oxidized nicotinamide adenine dinucleotide phosphate (NADP + ) to the respective reduced form, and a substrate for the reduction coexist.